论文部分内容阅读
目的:分析研究急性肺损伤采取糖皮质激素治疗的临床应用价值。方法:选取2013年1月-2014年4月在我院接收的患有急性肺损伤的病人一共有72例,随机分为观察组、对照组,对照组对病人采取临床常规治疗,观察组在此基础之上采取糖皮质激素(甲基强的松龙),对观察组与对照组病人的临床治疗效果给予对比分析。结果:观察组病人死亡率明显要比对照组低(P<0.05);观察组病人RR以及PaO2/Fio2改善情况明显优于对照组(P<0.05);观察组病人住院天数以及氧合指数恢复正常时间明显低于对照组(P<0.05)。结论:急性肺损伤采取糖皮质激素治疗,可以使病人死亡率明显减少,使病人住院天数进一步缩短,具有临床推广价值。
Objective: To analyze the clinical value of glucocorticoid therapy in acute lung injury. Methods: A total of 72 patients with acute lung injury received in our hospital from January 2013 to April 2014 were randomly divided into observation group, control group and control group. The patients in observation group were treated with Based on this to take glucocorticoid (methylprednisolone), the observation group and control group of patients with clinical treatment to give a comparative analysis. Results: The mortality rate in observation group was significantly lower than that in control group (P <0.05). The improvement of RR and PaO2 / Fio2 in observation group was significantly better than that in control group (P <0.05). The hospitalization days and oxygenation index recovery The normal time was significantly lower than the control group (P <0.05). Conclusion: The treatment of acute lung injury with glucocorticoid treatment can significantly reduce the patient’s mortality and shorten the hospitalization days, which is of clinical value.